Disseminated Macular Amyloidosis: Clinical Presentation
Disseminated (generalized) macular amyloidosis presents as widespread hyperpigmented macules extending beyond the typical upper back location to involve multiple body areas including the face, neck, extremities, trunk, and occasionally mucosa, often with a diffuse homogeneous pattern rather than the classic rippled appearance.
Key Clinical Features
The disseminated variant differs significantly from typical macular amyloidosis in its distribution and morphology:
Distribution Pattern
- Extensive involvement: Face, neck, arms, legs, trunk, axillae, groin, and sacral regions 1, 2, 3
- Contrasts with classic macular amyloidosis which typically localizes to the upper back between shoulder blades 4
Morphologic Characteristics
- Hyperpigmented macules with diffuse homogeneous pigmentation 2
- May present with poikilodermatous appearance (combination of hyperpigmentation, hypopigmentation, atrophy, and telangiectasia) 1
- Lace-like or reticulate erythema patterns possible 3
- Notably lacks the typical rippled pattern seen in localized disease 2
Associated Symptoms
- Pruritus is common, though some cases are non-pruritic 3
- Symptoms may be present for years before diagnosis (reported duration of 10 years in one case) 1
Diagnostic Considerations
Histopathology
- Subepidermal band-like amyloid deposits in papillary dermis 2
- Hyperkeratosis and acanthosis of epidermis 1
- Congo red staining positive with characteristic apple-green birefringence 3
Critical Diagnostic Pitfall
The diffuse hyperpigmentation can easily mimic other conditions including endocrine disorders, drug-induced pigmentation, heavy metal toxicity, polychlorinated biphenyl exposure, or post-inflammatory hyperpigmentation 2. Maintain high clinical suspicion and perform skin biopsy with Congo red staining when encountering widespread hyperpigmentation without clear alternative etiology.
Systemic Associations
While primary localized cutaneous amyloidosis traditionally does not require systemic workup, emerging evidence suggests screening for associated conditions:
- Hepatitis B and C co-infection has been reported with widespread macular amyloidosis 5
- Increasing reports link primary localized cutaneous amyloidosis with autoimmune diseases 5
- No systemic amyloid involvement is expected in true primary cutaneous disease 2, 3